Press release
Rugged Expansion Foreseen by Acetohydroxamic Acid Market During 2015 - 2023
A sample of this report is available upon request @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6502
Acetohydroxamic acid chiefly acts as an anti-microbial agent which inhibits the growth of urea splitting bacteria, those are majorly responsible for urinary tract infections. The urea splitting bacteria are responsible for forming struvite stones. These stones are formed in the presence of highly alkaline urine, having a pH value more than 7.2 and in an environment which is rich are in ammonia content. The ammonia is generated through the splitting of urea by colonization with bacteria that produce urease. The struvite stones generally comprise of 5 to 15 percent of the all the urinary tract stones which is a significant amount in urinary tract infections.
Acetohydroxamic acid plays a vital role in decreasing the effect of urea splitting bacteria causing severe urinary tract infections. Additionally, the elderly population, premature infants, infants born with congenital urinary tract malformation, diabetic patients and spinal cord-injured patients are highly susceptible to urinary tract infections. Considerable rise in diabetic patients across the globe is anticipated to drive the demand for acetohydroxamic acid in the next six years. Moreover, the infections associated with urea splitting bacteria being considerably significant in the geriatric population; the global rise in the geriatric population is likely to boost the demand for acetohydroxamic acid in the forecast period.
To view TOC of this report is available upon request @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=6502
Currently, the acetohydroxamic acid market is dominated by developed regions such as the U.S. and Europe majorly due to rise in the diabetic and geriatric populations that are highly susceptible to urinary tract infections. The increase in number of elderly population, premature infants, infants born with congenital urinary tract malformation, diabetic patients and spinal cord-injured patients are expected to propel the growth of acetohydroxamic acid market. The market for acetohydroxamic acid is expected to increase in eastern countries in next six years considering the potential benefits associated with of acetohydroxamic acid in treating urinary tract infections. Gradual increase in health awareness across developing regions will help acetohydroxamic acid market to flourish across the globe. Asia-Pacific countries such as China, India, Thailand, Indonesia and other developing countries in RoW are anticipated to be the upcoming market for acetohydroxamic acid.
Get access to full summary @: https://www.transparencymarketresearch.com/acetohydroxamic-acid-market.html
The potential application of acetohydroxamic acid in medical sector especially treating infections related with urinary tract is anticipated to create a lucrative option for other companies to penetrate in acetohydroxamic acid market. Some of the key players functioning in acetohydroxamic acid industry include Shangrao Newfuture Environment Protection Technology Co. Ltd, Mission Pharmacal Company, etc.
About US
Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact US
Abhishek Budholiya
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
Website: https://www.transparencymarketresearch.com/
Email: sales@transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rugged Expansion Foreseen by Acetohydroxamic Acid Market During 2015 - 2023 here
News-ID: 764896 • Views: …
More Releases from Transparency Market Research
Gas Compressor Market Outlook 2036: Global Industry Expected to Reach US$ 41.0 B …
The global gas compressor market was valued at US$ 23.2 Bn in 2025 and is projected to reach US$ 41.0 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. This steady growth trajectory reflects the structural importance of gas compression systems across upstream, midstream, and downstream gas value chains. Rising natural gas consumption, expansion of pipeline and LNG infrastructure, and national energy…
Anesthesia Drugs Market to be Worth USD 12.6 Bn by 2036 - By Drug / By Applicati …
The global anesthesia drugs market was valued at US$ 7.6 billion in 2025 and is projected to reach US$ 12.6 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2036. This steady growth trajectory reflects the essential and non-substitutable role of anesthesia drugs in modern healthcare systems. As surgical interventions continue to rise globally-across both elective and emergency procedures-the demand for safe, effective,…
Single-Atom Catalysts Market Size is Expected to Expand from US$ 177.8 Million t …
The global single-atom catalysts (SACs) market is poised for remarkable growth as industries seek highly efficient, cost-effective, and sustainable catalytic solutions. Valued at US$ 177.8 million in 2025, the market is projected to reach US$ 1,000.2 million by 2036, expanding at a robust compound annual growth rate (CAGR) of 17.0% from 2026 to 2036. This rapid expansion reflects the growing importance of advanced catalysis in energy, chemicals, environmental protection, and…
Non-specific Endonuclease Market to Reach USD 726.6 Million by 2036, Supported b …
The non-specific endonuclease market is witnessing steady growth, driven by the expanding use of molecular biology tools across biotechnology, pharmaceuticals, diagnostics, and academic research. Non-specific endonucleases are enzymes that cleave nucleic acids without requiring a specific recognition sequence, making them highly valuable for applications such as DNA/RNA degradation, sample preparation, viscosity reduction, and contamination control. Their broad activity profile differentiates them from restriction enzymes and enables versatile usage across multiple…
More Releases for Acetohydroxamic
Acetohydroxamic Acid Market worth $855.62 million by 2030, growing at a CAGR of …
The "Acetohydroxamic Acid Market by Formulation (Liquid, Tablets/Capsules), Distribution Channel (Hospital Pharmacies, Online Pharmacies), Application - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/acetohydroxamic-acid
Acetohydroxamic Acid (AHA) is a hydroxamic acid derivative commonly used for its antibacterial and urease inhibitory properties, primarily in the medical field to treat urinary tract infections (UTIs) caused by urease-producing bacteria. AHA's necessity lies in its ability to…
Renewable Propulsion for Marine Vessels Market Statistics and Research Analysis …
This enlightening Renewable Propulsion for Marine Vessels market study report works as the best guide for retailers and key participants to obtain thorough explanation regarding economic expansion elements of the industry. It portrays the latest market position for the purpose of assisting business players to develop a clear vision to increase the business sales. Valuable data acquired here is the outcome of necessary surveys taken from emerging industries. By doing…
Acetohydroxamic Acid Market 2021-2028: Trends, Business Growth And Major Driving …
Acetohydroxamic acid is a drug that is primarily used to treat urinary tract infections. Acetohydroxamic acid is a synthetic drug derived from hydroxylamine and ethyl acetate, is similar in structure to urea. Acetohydroxamic acid prevents the growth of bacterial enzymes and stops the hydrolysis of urea and brings down the production of ammonia in urine.
Some of the key players profiled in the Acetohydroxamic Acid Market include Hangzhou Lingrui Chemical, Zhejiang…
Acetohydroxamic Acid Market Size & Growth Analysis Report, 2021-2027
Acetohydroxamic Acid Market size is forecast to reach around $510.33 million by 2027, after growing at a CAGR of 5% during 2021-2027.
Acetohydroxamic acid is a drug primarily used to treat urinary tract infections. Acetohydroxamic acid is a synthetic drug derived from hydroxylamine and ethyl acetate, similar in structure to urea. Acetohydroxamic acid prevents the growth of bacterial enzymes, stops the hydrolysis of urea, and reduces ammonia production in the urine.…
Acetohydroxamic Acid Market Size, Industry Status, Growth opportunity, Leading P …
The research study is a highly useful tool in the hands of market players that allows them to effectively assess the global Acetohydroxamic Acid market and know where they stand in the industry in terms of revenue or sales growth. It comprehensively evaluates the global Acetohydroxamic Acid market with different perspectives for the purpose of providing a detailed, informative, and accurate analysis of regional growth, competition, market segmentation, and other…
Global Acetohydroxamic Acid Market 2018-2025 | Top Venders : Hangzhou Dayangchem …
Global Acetohydroxamic Acid Market report is designed in a method that helps readers to acquire a complete knowledge about the overall market scenario for the projected period. This Market report consists of the brief profile of key players in the industry and their upcoming market plans and current developments during the forecasted period 2018 to 2025.
The report of global Acetohydroxamic Acid market includes the competitive landscape section which provides the…
